TLIS (Talis Biomedical) Insider Ownership: 18.26 % (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TLIS Talis Biomedical Corp TLIS
28 GF Score
Price $2.84
View Full Analysis

What is Talis Biomedical Insider Ownership?

Talis Biomedical TLIS 28 Insider Ownership is 18.26 % as of Aug. 10, 2026. GuruFocus rates TLIS with a GF Score™ of 28/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Talis Biomedical's insider ownership is 18.26%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Talis Biomedical's Institutional Ownership is 13.65%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Talis Biomedical's Float Percentage Of Total Shares Outstanding is 63.91%.

Talis Biomedical Insider Ownership Historical Data

* Premium members only.

The historical data trend for Talis Biomedical's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talis Biomedical Insider Ownership Chart

Talis Biomedical Historical Data

The historical data trend for Talis Biomedical can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 18.26 18.26 18.26 18.26 18.26 18.26 18.26 18.26 18.26 18.26
TLIS
28GF Score
Talis Biomedical Corp TLIS
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Talis Biomedical Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 18.26 % mean?
Talis Biomedical (TLIS) has a Insider Ownership of 18.26 % as of Aug. 10, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Talis Biomedical and its competitors.
Is Talis Biomedical's Insider Ownership too high?
Talis Biomedical's current Insider Ownership is 18.26 %. Overall, Talis Biomedical has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Talis Biomedical's Insider Ownership compare to BJDX and BBLG?
Talis Biomedical's Insider Ownership of 18.26 % can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Devices & Instruments company?
A good Insider Ownership depends on the Medical Devices & Instruments industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Talis Biomedical and its competitors. Talis Biomedical's current Insider Ownership is 18.26 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talis Biomedical stock overvalued right now?
Talis Biomedical (TLIS) has a current Insider Ownership of 18.26 %. The current Insider Ownership is 18.26 %. Talis Biomedical's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Talis Biomedical (TLIS), the current Insider Ownership is 18.26 % as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Talis Biomedical Business Description

Address 1375 West Fulton Market, Suite 700, Chicago, IL, USA, 60607
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
28GF Score

Get the complete analysis for TLIS

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.84
Price